Total raised
—
Last: Pre-Seed
Stage
Pre-Seed
Founded
2012
Headcount
4
HQ
Pardes Hanna-Karkur
Sector
Health Tech & Life Sciences
About
MitralCord is developing a simple, minimally invasive "place and forget" transcathetertransseptal solution for mitral valve regurgitation, one of the primary types of heart disease worldwide. Based on standard cardiac procedures and materials, MitralCord's solution is performed on a beating heart and eliminates the risks of open surgery, enabling a minimal hospitalization period and short patient recovery time for improved patient wellbeing and quality of life. The solution is well into its R&D phase, already successfully passing the proof-of-concept stage and several preclinical animal studies.
Funding history · 1 round · — total
Date unknown
Pre-Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MitralCord's primary focus?
- MitralCord is developing a minimally invasive transcathetertransseptal solution for mitral valve regurgitation.
- When was MitralCord founded?
- MitralCord was founded in June 2012.
- What is the current operational status of MitralCord?
- MitralCord is currently inactive, having ceased operations in December 2019.
- Where is MitralCord's headquarters located?
- MitralCord's headquarters is in Pardes Hanna-Karkur, Israel.
- What stage of funding did MitralCord reach?
- MitralCord reached the Pre-Seed funding stage, with The Carel Group listed as an investor.
- How many employees did MitralCord have?
- MitralCord had 4 employees.
- Has MitralCord conducted any preclinical studies?
- Yes, MitralCord's solution successfully passed the proof-of-concept stage and several preclinical animal studies.
- Does MitralCord hold any patents?
- Yes, MitralCord holds 1 patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2C
Highlights
1 Patents
Tags
heart-diseasesheart-failurehealthcare-providersminimally-invasivecardiologyhospitalssurgeonsmedical-devices